| Review of the Cosolvency Models for Predicting Drug Solubility in Solvent Mixtures: An Update |
14 |
| Drug Targeting Strategies Based on Charge Dependent Uptake of Nanoparticles into Cancer Cells |
14 |
| Understanding the Monoclonal Antibody Disposition after Subcutaneous Administration using a Minimal Physiologically based Pharmacokinetic Model |
11 |
| Preparation and Characterization of Spray-Dried Inhalable Powders Containing Polymeric Micelles for Pulmonary Delivery of Paclitaxel in Lung Cancer |
10 |
| Inhibition of TLR4/TRIF/IRF3 Signaling Pathway by Curcumin in Breast Cancer Cells |
9 |
| Microneedles as Enhancer of Drug Absorption Through the Skin and Applications in Medicine and Cosmetology |
9 |
| Anticancer Drug-Induced Epithelial-Mesenchymal Transition via p53/miR-34a axis in A549/ABCA3 Cells |
8 |
| Functionalized Caprolactone-Polyethylene Glycol Based Thermo-Responsive Hydrogels of Silibinin for the Treatment of Malignant Melanoma |
5 |
| Effects of Canagliflozin on Fatty Liver Indexes in Patients with Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials |
5 |
| PAMAM-dendrimer Enhanced Antibacterial Effect of Vancomycin Hydrochloride Against Gram-Negative Bacteria |
5 |
| Purchasing Over The Counter (OTC) Medicinal Products Containing Codeine - Easy Access, Advertising, Misuse and Perceptions of Medicinal Risk |
5 |
| Drugs Loaded into Electrospun Polymeric Nanofibers for Delivery |
5 |
| in vitro- and in vivo Evaluation of Methotrexate-Loaded Hydrogel Nanoparticles Intended to Treat Primary CNS Lymphoma via Intranasal Administration |
4 |
| A Case for Alpha-Lipoic Acid as an Alternative Treatment for Diabetic Polyneuropathy |
4 |
| Resveratrol Limits Lipogenesis and Enhance Mitochondrial Activity in HepG2 Cells |
4 |
| Nano-sized Droplets of Self-Emulsifying System for Enhancing Oral Bioavailability of Chemotherapeutic Agent VP-16 in Rats: A Nano Lipid Carrier for BCS Class IV Drugs |
4 |
| Clearance Concepts: Fundamentals and Application to Pharmacokinetic Behavior of Drugs |
4 |
| Therapeutic Applications of Ethanol: A Review |
3 |
| Understanding the Role of Sodium Lauryl Sulfate on the Biorelevant Solubility of a Combination of Poorly Water-Soluble Drugs Using High Throughput Experimentation and Mechanistic Absorption Modeling |
3 |
| Positron Emission Tomography (PET) and Pharmacokinetics: Classical Blood Sampling Versus Image-Derived Analysis of [F-18]FAZA and [F-18]FDG in a Murine Tumor Bearing Model |
3 |
| Diclofenac-Acetaminophen Combination Induced Acute Kidney Injury In Postoperative Pain Relief |
3 |
| In Endothelial Cells, the Activation or Stimulation of Soluble Guanylyl Cyclase Induces the Nitric Oxide Production by a Mechanism Dependent of Nitric Oxide Synthase Activation |
3 |
| A Survey of the Regulatory Requirements for BCS-Based Biowaivers for Solid Oral Dosage Forms by Participating Regulators and Organisations of the International Generic Drug Regulators Programme |
3 |
| Mining Small Routine Clinical Data: A Population Pharmacokinetic Model and Optimal Sampling Times of Capecitabine and its Metabolites |
3 |
| PPAR gamma Agonist, Pioglitazone, Suppresses Melanoma Cancer in Mice by Inhibiting TLR4 Signaling |
3 |
| Therapeutic Drug Monitoring of Levetiracetam in Select Populations |
3 |
| Effect of Bile Duct Ligation-induced Liver Dysfunction on Methamphetamine Pharmacokinetics and Locomotor Activity in Rats |
2 |
| Research on the Scientific Evolution of the Flavonoid Agathisflavone |
2 |
| Endotoxin Modulates the Expression of Renal Drug Transporters in HIV-1 Transgenic Rats |
2 |
| Effects of Three Anti-Seizure Drugs on Cholinergic and Metabolic Activity in Experimental Status Epilepticus |
2 |
| A Survey of the Regulatory Requirements for the Acceptance of Foreign Comparator Products by Participating Regulators and Organizations of the International Generic Drug Regulators Programme |
2 |
| Association Between HLA genotypes and Oxcarbazepine-induced Cutaneous Adverse Drug Reactions: A Systematic Review and Meta-Analysis |
2 |
| Evaluation of the Benefits of De-Escalation for Patients with Sepsis in the Emergency Intensive Care Unit |
2 |
| Considerations and Pitfalls in Selecting the Drug Vehicles for Evaluation of New Drug Candidates: Focus on &ITin vivo&IT Pharmaco-Toxicological Assays Based on the Rotarod Performance Test |
2 |
| Inhibition of BMP4 and Alpha Smooth Muscle Actin Expression in LX-2 Hepatic Stellate Cells by BMP4-siRNA Lipid Based Nanoparticle |
2 |
| Norfloxacin, a Fluoroquinolone Antibiotic, Inhibits Langerhans Cell-Mediated Th1 and Th2 Cell Development |
2 |
| Clinical Outcomes of Aspirin Interaction with Other Non-Steroidal Anti-Inflammatory Drugs: A Systematic Review |
2 |
| Effects of Orotic Acid-Induced Non-Alcoholic Fatty Liver on the Pharmacokinetics of Metoprolol and its Metabolites in Rats |
2 |
| Novel Approaches for Efficient Delivery of Tyrosine Kinase Inhibitors |
2 |
| Licofelone Attenuates LPS-induced Depressive-like Behavior in Mice: A Possible Role for Nitric Oxide |
2 |
| Evaluation of Ion-pair Formation of Adefovir to Improve Permeation across Artificial and Biological Membranes |
2 |
| Inhibitory Effects of Baicalein Derived from Japanese Traditional Herbal Medicine on SN-38 Glucuronidation |
2 |
| Factors Affecting Opioid Treatment in Cancer Patients |
1 |
| Therapeutic Doses of Eltrombopag do not Inhibit Hepatic BCRP in Healthy Volunteers: Intravenous Ceftriaxone as a Model |
1 |
| An Update on Drug-induced Oral Reactions |
1 |
| The Requirements for Additional Strength Biowaivers for Immediate Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities |
1 |
| Analysis of the Association Between Polymorphisms within PAI-1 and ACE genes and Ischemic Stroke Outcome After rt-PA Therapy |
1 |
| Comparison of Steroid Hormone Hydroxylations by and Docking to Human Cytochromes P450 3A4 and 3A5 |
1 |
| Lifitegrast Ophthalmic Solution 5.0% for Treatment of Dry Eye Disease: Overview of Clinical Trial Program |
1 |
| Decrease in Multidrug Resistance-associated Protein 2 Activities by Knockdown of Phosphatidylinositol 4-phosphate 5-kinase in Hepatocytes and Cancer Cells |
1 |